Eli Lilly stock is way up over the past year, but analysts who follow the company think it still has more upside. Sales of Eli Lilly's weight-management treatment are soaring and could climb much ...

(Bloomberg) -- Eli Lilly & Co.’s shares soared as its brighter outlook for 2024 raised the potential ceiling for new weight-loss drugs even further in the eyes of analysts and investors.

Eli Lilly's Mounjaro is a diabetes medication that competes with Novo Nordisk's Ozempic. Lilly is making strides in the weight-loss market, and its newest treatment may be a smashing success.

Eli Lilly (NYSE: LLY) stock has been a top performer thanks to runaway sales of its diabetes-turned-weight-management treatment. Despite nearly doubling over the past 12 months, Eli Lilly stock ...

After 65 years, a Palm Beach fashion mainstay's logo is getting a refresh. The Lilly Pulitzer logo update kicks off a refresh for the brand to mark its 65th anniversary, with the new logo rolling ...

Dave M. Benett/Getty Lily Allen had quite the one-sided feud with Elton John. The British pop star, 39, used to be a client of a management company owned by the "Rocket Man" icon, but she was ...

Despite Eli Lilly’s assurances about an ample supply of its new weight loss drug Zepbound, the company is now facing widespread shortages just months after its approval. While the drugmaker is ...

Donanemab treatment slowed clinical decline by 35% compared to placebo. Lilly continues to study donanemab in multiple clinical trials, including TRAILBLAZER-ALZ-3, for the prevention of Alzheimer's.

Ben Schnetzer has joined the cast of the upcoming Lily James-led film inspired by the story of Bumble founder and former CEO Whitney Wolfe Herd, from 20th Century Studios and Ethea Entertainment.

The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the second quarter of 2024 of $1.30 per share on outstanding common stock. Eli Lilly and Company (NYSE ...

Danish pharmaceutical giant Novo Nordisk is the maker of both. However, Eli Lilly (NYSE: LLY) is making a name for itself in the diabetes and chronic weight management markets. The company's ...